World’s Largest Food Companies Call on EU to Include Novel Foods in Regulatory Sandboxes

Why It Matters

Including novel foods in EU sandboxes would align the regulatory framework with the Act’s innovation goals, reducing approval delays for high‑growth alternative‑protein products. This could boost investment and competitiveness of Europe’s food sector against global rivals.

Key Takeaways

• EU excludes novel foods from biotech sandboxes.
• Major food firms demand inclusion for cultivated meat, proteins.
• Exclusion creates regulatory incoherence, hampers innovation.
• UK sandbox shows benefits for novel food development.
• Inclusion would improve EFSA pre‑submission dialogue and safety assessments.

Pulse Analysis

The European Union’s Biotech Act, unveiled in December, introduced regulatory sandboxes intended to streamline the approval of emerging food technologies. While the sandboxes cover enzymes, additives, and AI‑driven processes, they explicitly bar novel foods—products that do not have a history of safe consumption in the EU. Industry leaders argue this carve‑out is not grounded in scientific risk assessment but rather in perceived ethical or cultural concerns, creating a regulatory gap that contradicts the Act’s stated aim of fostering biomanufacturing innovation.

For the alternative‑protein sector, the exclusion is especially consequential. Cultivated meat and precision‑fermented proteins rely on cutting‑edge biotech that can benefit from early regulator‑industry dialogue, data‑sharing, and iterative testing—advantages that sandboxes provide. The United Kingdom’s cultivated‑meat sandbox, launched in early 2025, has already yielded safety guidance and is on track to approve its first products by next year. This precedent demonstrates how sandbox environments can de‑risk development, lower costs, and accelerate market entry, offering a blueprint the EU could emulate to keep pace with global competitors.

From an investment and market‑growth perspective, aligning novel foods with the sandbox framework would likely unlock significant capital flows into European food‑tech startups. A coherent, science‑based pathway reduces uncertainty, shortens time‑to‑market, and reassures consumers that safety assessments remain rigorous. As consumer demand for sustainable protein rises, policymakers face pressure to harmonise regulations with innovation cycles. Including novel foods in the EU sandboxes would not only resolve the current incoherence but also reinforce the EU’s position as a leader in sustainable food innovation.